GlassScriptPhysician profile
Victor X Du
NPI 1245506468
$5,131.14
in general payments reported to CMS, 2019-2025
17 companies · $946 in 2025
The $946 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,901 · 2020: $964 · 2021: $417 · 2022: $205 · 2023: $414 · 2024: $285 · 2025: $946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,363 · Travel and Lodging: $216 · Education: $65.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,362.51 |
| Travel and Lodging | $215.94 |
| Education | $65.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $1,749.97 | 2019-2025 | Senza, Si-Lok, Excelsiusgps Robotic Navigation System |
| Nuvasive, INC. | $1,709.28 | 2019-2023 | Modulus, Reline, Xlif |
| Boston Scientific Corporation | $643.66 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $294.98 | 2021-2024 | Senza |
| Si-Bone, INC. | $166.57 | 2020-2024 | |
| Stryker Corporation | $118.49 | 2019-2020 | |
| Medtronic, INC. | $105.47 | 2021-2022 | |
| Medtronic USA, INC. | $71.33 | 2020 | |
| Cerapedics INC. | $65.65 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Arbor Pharmaceuticals, INC. | $36.01 | 2019 | |
| Saluda Medical Americas, INC. | $32.23 | 2025 | Evoke |
| Genentech USA, INC. | $31.69 | 2025 | Ocrevus Zunovo |
| Abbvie INC. | $28.94 | 2025 | |
| Orthofix Medical, INC. | $26.81 | 2021 | |
| Abbott Laboratories | $23.16 | 2025 | Proclaim |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spine Wave, INC. | $17.62 | 2025 | Annex Adjacent Level System |
| Longeviti Neuro Solutions INC | $9.28 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Du listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.